SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002837
Filing Date
2021-11-03
Accepted
2021-11-03 16:31:05
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20210930.htm   iXBRL 10-Q 3126745
2 EX-31.1 tyra-ex31_1.htm EX-31.1 19384
3 EX-31.2 tyra-ex31_2.htm EX-31.2 19612
4 EX-32.1 tyra-ex32_1.htm EX-32.1 10824
5 EX-32.2 tyra-ex32_2.htm EX-32.2 10801
  Complete submission text file 0000950170-21-002837.txt   7986947

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20210930.xsd EX-101.SCH 42068
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20210930_def.xml EX-101.DEF 138643
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20210930_pre.xml EX-101.PRE 255612
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20210930_cal.xml EX-101.CAL 39655
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20210930_lab.xml EX-101.LAB 359063
11 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20210930_htm.xml XML 1175833
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 211375940
SIC: 2834 Pharmaceutical Preparations